CRGGF(CRGGF)
CRGGF
No analyst ratings available
No analyst price targets available for CRGGF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $101.88B | $102.97B | $104.71B | $108.77B | $120.28B |
| Low | $98.25B | $97.00B | $99.80B | $103.68B | $114.64B |
| High | $106.38B | $107.80B | $109.48B | $113.73B | $125.76B |
| EBITDA Avg | $9.42B | $9.82B | $10.24B | $10.98B | $12.37B |
| Low | $9.15B | $9.55B | $9.96B | $10.66B | $11.99B |
| High | $9.67B | $10.08B | $10.52B | $11.28B | $12.74B |
| EBIT Avg | $5.09B | $5.23B | $5.42B | $5.93B | $7.01B |
| Low | $4.83B | $4.96B | $5.14B | $5.61B | $6.63B |
| High | $5.35B | $5.49B | $5.70B | $6.23B | $7.38B |
| Net Income Avg | $3.41B | $3.52B | $3.67B | $4.07B | $4.93B |
| Low | $3.20B | $3.30B | $3.45B | $3.82B | $4.63B |
| High | $3.61B | $3.73B | $3.89B | $4.31B | $5.22B |
| EPS Avg | $1.49 | $1.54 | $1.60 | $1.78 | $2.15 |
| Low | $1.40 | $1.44 | $1.51 | $1.67 | $2.02 |
| High | $1.58 | $1.63 | $1.70 | $1.88 | $2.28 |
| Analysts (Rev / EPS) | 17 / 1 | 17 / 1 | 8 / 1 | 13 / 1 | 8 / 1 |